Felipe Saceanu Leser

Felipe Saceanu Leser

Auto-generated profile, based on publicly available information

Felipe Saceanu Leser

Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LBLigia Simoes Braga Boisserand
Ligia Simoes Braga Boisserand
LGLuiz Henrique Geraldo
Luiz Henrique Geraldo
JBJean Bouchart
Jean Bouchart
MKMarie-Renee El Kamouh
Marie-Renee El Kamouh
SLSeyoung Lee
Seyoung Lee
JTJean-Leon Thomas
Jean-Leon Thomas
Meningeal lymphatic vessels (MLVs) promote tissue clearance and immune surveillance in the central nervous system (CNS). Vascular endothelial growth factor-C (VEGF-C) regulates MLV development and maintenance and has therapeutic potential for treating neurological disorders. Herein, we investigated the effects of VEGF-C overexpression on brain fluid drainage and ischemic stroke outcomes in mice. Intracerebrospinal administration of an adeno-associated virus expressing mouse full-length VEGF-C (AAV-mVEGF-C) increased CSF drainage to the deep cervical lymph nodes (dCLNs) by enhancing lymphatic growth and upregulated neuroprotective signaling pathways identified by single nuclei RNA sequencing of brain cells. In a mouse model of ischemic stroke, AAV-mVEGF-C pretreatment reduced stroke injury and ameliorated motor performances in the subacute stage, associated with mitigated microglia-mediated inflammation and increased BDNF signaling in brain cells. Neuroprotective effects of VEGF-C were lost upon cauterization of the dCLN afferent lymphatics and not mimicked by acute post-stroke VEGF-C injection. We conclude that VEGF-C prophylaxis promotes multiple vascular, immune, and neural responses that culminate in a protection against neurological damage in acute ischemic stroke.

1 January 2019 in Trends in Cancer
Verified
Journal Article
Closed access
LGLuiz Henrique Medeiros Geraldo
Luiz Henrique Medeiros Geraldo
CGCelina Garcia
Celina Garcia
AFAnna Carolina Carvalho da Fonseca
Anna Carolina Carvalho da Fonseca
LDLuiz Gustavo Feijó Dubois
Luiz Gustavo Feijó Dubois
TSTânia Cristina Leite de Sampaio e Spohr
Tânia Cristina Leite de Sampaio e Spohr
FLFlavia Regina Souza Lima
Flavia Regina Souza Lima

3 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
TIThe Brazilian Reproducibility Initiative
The Brazilian Reproducibility Initiative
OAOlavo Bohrer Amaral
Olavo Bohrer Amaral
CCClarissa França Dias Carneiro
Clarissa França Dias Carneiro
KNKleber Neves
Kleber Neves
ASAna Paula Wasilewska Sampaio
Ana Paula Wasilewska Sampaio
WAWanessa Fernanda Altei
Wanessa Fernanda Altei
Concerns over the replicability and reproducibility of published research have grown in many research fields, but empirical data to inform policies are still scarce. Biomedical research in Brazil expanded rapidly over the last three decades, with no systematic assessment of the replicability of its findings. With this in mind, we set up the Brazilian Reproducibility Initiative, a multicenter replication of published experiments from Brazilian science using three common experimental methods: the MTT assay, the reverse transcription polymerase chain reaction (RT-PCR) and the elevated plus maze (EPM). A total of 56 laboratories performed 143 replications of 56 experiments; of these, 90 replications of 45 experiments were considered valid by an independent committee. Replication rates for these experiments varied between 20 and 44% according to five predefined criteria. In median terms, ratios between group means were 58% lower in replications than in original experiments, while coefficients of variation were 82% higher. Effect size decrease was smaller for MTT experiments, original results with less variability and those considered more challenging to replicate, while t values for replications were positively correlated with researcher predictions about replicability, and negatively correlated with the rate of publications by the original article’s last author. Deviations from preregistered protocols were very common in replications, most frequently due to reasons inherent to the experimental model or related to infrastructure and logistics. Our results highlight factors that limit the replicability of results published by researchers in Brazil and suggest ways by which this scenario can be improved.

20 November 2024 in Science Translational Medicine
Verified
Journal Article
Closed access
LGLuiz Henrique Geraldo
Luiz Henrique Geraldo
YXYunling Xu
Yunling Xu
GMGaspard Mouthon
Gaspard Mouthon
JFJessica Furtado
Jessica Furtado
FLFelipe Saceanu Leser
Felipe Saceanu Leser
AEAnne Eichmann
Anne Eichmann
Roundabout (ROBO) 1 and 2 are transmembrane receptors that bind secreted SLIT ligands through their extracellular domains (ECDs) and signal through their cytoplasmic domains to modulate the cytoskeleton and regulate cell migration, adhesion, and proliferation. SLIT-ROBO signaling regulates pathological ocular neovascularization, which is a major cause of vision loss worldwide, but pharmacological tools to prevent SLIT-ROBO signaling are lacking. Here, we developed human monoclonal antibodies (mAbs) against the ROBO1 and ROBO2 ECDs. One antibody that inhibited in vitro SLIT2 signaling through ROBO1 and ROBO2 (anti-ROBO1/2) also reduced ocular neovascularization in oxygen-induced retinopathy (OIR) and laser-induced corneal neovascularization (CNV) mouse models in vivo. Single-cell RNA sequencing of OIR retinas revealed that antibody treatment affected several cell types relevant to physiological and pathological angiogenesis, including endothelial cells, pericytes, and a heterogeneous population of myeloid cells. mAb treatment improved blood-retina barrier integrity and prevented pathological pericyte activation in OIR. SLIT-ROBO signaling inhibition prevented pathological activation of myeloid cells and increased neuroprotective myeloid populations normally seen in the developing retina. Microglia/infiltrating macrophage–specific ablation of Robo1 and Robo2 or knockout of the downstream effector phosphatidylinositol 3-kinase ( Pik3cg ) encoding PI3Kγ in both OIR and CNV models phenocopied anti-ROBO1/2 treatment, further demonstrating the key role of myeloid cells as drivers of ocular neovascular diseases. ROBO1/2 blocking antibodies may thus provide a promising strategy to combat inflammation in blinding eye diseases.

22 July 2026 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
MKMarie-Renee El Kamouh
Marie-Renee El Kamouh
MSMyriam Spajer
Myriam Spajer
RSRuchith Singhabahu
Ruchith Singhabahu
AMAnne-Laure Joly Marolany
Anne-Laure Joly Marolany
KSKurt A. Sailor
Kurt A. Sailor
SLStéphanie Lenck
Stéphanie Lenck
Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure and dural venous sinus stenoses, which can be relieved by venous stenting. Here we investigated whether venous blood flow may play a role in controlling brain pressure. Using magnetic resonance imaging in patients with IIH and healthy controls, we identified that dural venous stenoses in IIH were associated with alterations of the perivenous fluid pattern and brain edema. We developed a mouse model of jugular vein ligation (JVL), which developed transient intracerebral hypertension, brain edema and impaired brain clearance, along with defective meningeal lymphatic vessels (MLVs). MLV depletion increased intracerebral pressure in control and JVL mice, but only MLV-deficient ligated mice failed to restore brain fluid clearance. These findings implicate MLVs in the control of intracerebral pressure and establish the dural venous sinuses as critical platforms where venous flow directs MLVs to ensure brain fluid clearance.

27 November 2023 in Mental Health Science
Verified
Journal Article
Open access
FLFelipe Saceanu Leser
Felipe Saceanu Leser
MRMirella Araújo Ribeiro
Mirella Araújo Ribeiro
LSLucas Dalsente Romano da Silva
Lucas Dalsente Romano da Silva
RDRenato Garcia Domingues
Renato Garcia Domingues
Tiago OuteiroTiago Outeiro
Tiago Outeiro
PGPhelippe Do Carmo Gonçalves
Phelippe Do Carmo Gonçalves
In 2020, the novel severe acute respiratory syndrome coronavirus outbreak emerged as a public health emergency. Three years later, we are still assessing the effects caused by the coronavirus disease (COVID‐19) and by the lifestyle changes due to prevention measures, like social isolation. Here, we assessed the profile of both the anxiety screening scores and anthropometric variables in the university community, associated with the isolation due to the COVID‐19 pandemic. We analyzed social and epidemiological associated factors for anxiety and weight change to address and better identify the physical and mental conditions aggravated during the pandemic. This is a cross‐sectional study based on the 7‐item Generalized Anxiety Disorder Scale questionnaire applied virtually to university students and professors in the State of Rio de Janeiro (n = 480). In our population cohort, we showed that the majority of individuals showed moderate to severe anxiety and increased body weight during the COVID‐19 pandemic. The major demographic associated factors for higher anxiety levels were young age, female gender, and low family income. The main modifiable associated factors for both anxiety and weight gain were the negative changes in living habits. In addition, there was a trend toward severe anxiety and greater weight change in people with increased time in social isolation. In view of these results, we suggest that bad habits, adopted during the COVID‐19 pandemic, were the main reason for the high anxiety levels found in the studied population.